Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | CA12 | O43570 | 2/20 | 0.35 |
| ▸ | CA1 | P00915 | 2/20 | 0.35 |
| ▸ | CA2 | P00918 | 2/20 | 0.35 |
| ▸ | CA9 | Q16790 | 2/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.35 |
| ▸ | MGAM | O43451 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | SI | P14410 | 1/20 | 0.35 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.35 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.32 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL618027 | 0.75 | ALDH1A1 (0.38) | ALDH1A1HSD17B10LMNACA12CA1 | |
| SCHEMBL5763396 | 0.73 | — | — | |
| SCHEMBL5126316 | 0.71 | — | — | |
| SCHEMBL10999813 | 0.71 | — | — | |
| SCHEMBL13901279 | 0.71 | — | — | |
| SCHEMBL77241 | 0.71 | — | — | |
| SCHEMBL20473237 | 0.71 | — | — | |
| SCHEMBL25093 | 0.69 | — | — | |
| SCHEMBL23630444 | 0.69 | — | — | |
| SCHEMBL17200952 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 68 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024064962-A2 | IMMUNO-PCR AND NEXT GENERATION SEQUENCING FOR PRECISE ANTIGEN QUANTITATION | SLINGSHOT BIOSCIENCES, INC. (US) | 2024-03-28 | — | — | WO | claimed |
| WO-2023094815-A1 | SEPARATION MEMBRANE | G2O WATER TECHNOLOGIES LIMITED (GB) | 2023-06-01 | — | — | WO | claimed |
| US-8716530-B2 | Facially amphiphilic polyaryl and polyarylalkynyl polymers and oligomers and uses thereof | THE TRUSTESS OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2014-05-06 | — | — | US | claimed |
| US-20120202887-A1 | Facially Amphiphilic Polyaryl and Polyarylalkynyl Polymers and Oligomers and Uses Thereof | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2012-08-09 | — | — | US | claimed |
| EP-2468711-A2 | Facially amphiphilic polyaryl and polarylalkynyl polymers and oligomers and uses thereof | The Trustees Of The University Of Pennsylvania (US) | 2012-06-27 | — | — | EP | claimed |
| EP-2433627-A1 | Facially amphiphilic polymers and oligomers, compositions thereof, and use thereof in methods of treating cancer | The Trustees Of The University Of Pennsylvania (US) | 2012-03-28 | — | — | EP | claimed |
| EP-2301349-A2 | Facially amphiphilic polymers and oligomers, compositions thereof, and use thereof in methods of treating cancer | The Trustees of The University of Pennsylvania (US) | 2011-03-30 | — | — | EP | claimed |
| EP-2298074-A2 | Facially amphiphilic polymers and oligomers, compositions thereof, and use thereof in methods of treating cancer | The Trustees Of The University Of Pennsylvania (US) | 2011-03-23 | — | — | EP | claimed |
| EP-2289524-A1 | Facially amphiphillic polymers as anti-infective agents | The Trustees Of The University Of Pennsylvania (US) | 2011-03-02 | — | — | EP | claimed |
| US-20100065499-A1 | COMPOSITE MATERIAL | JACOBS UNIVERSITY BREMEN GGMBH (DE) | 2010-03-18 | — | — | US | claimed |
| JP-2005530842-A | — | — | 2005-10-13 | — | — | JP | claimed |
| WO-2005072246-A2 | FACIALLY AMPHIPHILIC POLYARYL AND POLYARYLALKYNYL POLYMERS AND OLIGOMERS AND USES THEREOF | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2005-08-11 | — | — | WO | claimed |
| EP-1515705-A1 | FLUOROSILOXANE MATRIX CONTROLLED DIFFUSION DRUG DELIVERY SYSTEM | BAUSCH & LOMB INCORPORATED (US) | 2005-03-23 | — | — | EP | claimed |
| US-20040202639-A1 | Microbiocide surfaces; antiseptics; contact lenses, catheters | NATIONAL SCIENCE FOUNDATION | 2004-10-14 | — | — | US | claimed |
| EP-1372674-A4 | FACIALLY AMPHIPHILIC POLYMERS AS ANTI-INFECTIVE AGENTS | UNIV PENNSYLVANIA (US) | 2004-05-12 | — | — | EP | claimed |
| WO-2004035012-A1 | THE USE OF BIOMIMIC POLYMERS IN PERSONAL CARE COMPOSITIONS | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2004-04-29 | — | — | WO | claimed |
| EP-1372674-A2 | FACIALLY AMPHIPHILIC POLYMERS AS ANTI-INFECTIVE AGENTS | UNIVERSITY OF PENNSYLVANIA (US) | 2004-01-02 | — | — | EP | claimed |
| WO-2004000288-A1 | FLUOROSILOXANE MATRIX CONTROLLED DIFFUSION DRUG DELIVERY SYSTEM | BAUSCH & LOMB INCORPORATED (US) | 2003-12-31 | — | — | WO | claimed |
| WO-2002072007-A2 | FACIALLY AMPHIPHILIC POLYMERS AS ANTI-INFECTIVE AGENTS | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2002-09-19 | — | — | WO | claimed |
| US-5316704-A | Deformed into elongation configuration; surgery insertion | KABI PHARMACIA OPHTHALMICS INC. (US) | 1994-05-31 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040202639-A1 | Microbiocide surfaces; antiseptics; contact lenses, catheters | POLR1C, CD74, ABHD16A | ALDH1A1 3909/4885HSD17B10 503/4885LMNA 3767/4885 |
| US-20120202887-A1 | Facially Amphiphilic Polyaryl and Polyarylalkynyl Polymers and Oligomers and Uses Thereof | TLR3, ABHD16A, ANTXR2 | ALDH1A1 4738/4885HSD17B10 1168/4885LMNA 1399/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.